Literature DB >> 32429746

In Vitro and In Vivo Interspecies Chimera Assay Using Early Pig Embryos.

Monika Nowak-Imialek1,2, Stephanie Wunderlich3, Doris Herrmann1, Svenja Breitschuh-Leibling4, Gudrun Gohring5, Björn Petersen1, Sabine Klein1, Ulrich Baulain1, Andrea Lucas-Hahn1, Ulrich Martin2,3, Heiner Niemann1,2.   

Abstract

Chimeric pigs harboring organs derived from human stem cells are promising for patient-specific regenerative therapies. Induced pluripotent stem cells (iPSCs) can contribute to all cell types of the fetus, including germline after injection into embryos. However, ethical concerns prohibit testing human iPSCs in chimera assays. Here, we evaluated porcine embryos as hosts for an interspecies chimera assay using iPSCs from either cynomolgus monkeys (cyiPSCs) or mouse (miPSCs). To establish an in vitro culture system compatible for cyiPSCs and porcine embryos, we determined blastocyst development in eight different stem cell media. The highest developmental rates of blastocysts were achieved in Knockout Dulbecco's modified Eagle's medium with 20% knockout serum replacement. We found that cyiPSCs injected into porcine embryos survived in vitro and were mostly located in the trophectoderm (TE). Instead, when miPSCs were injected into porcine embryos, the cells rapidly proliferated. The behavior of chimeras developed in vitro was recapitulated in vivo; cyiPSCs were observed in the TE, but not in the porcine epiblast. However, when miPSCs were injected into in vivo derived porcine embryos, mouse cells were found in both, the epiblast and TE. These results demonstrate that porcine embryos could be useful for evaluating the interspecies chimera-forming ability of iPSCs from different species.

Entities:  

Keywords:  chimera assay; embryos; iPSCs; interspecies; porcine

Mesh:

Substances:

Year:  2020        PMID: 32429746     DOI: 10.1089/cell.2019.0107

Source DB:  PubMed          Journal:  Cell Reprogram        ISSN: 2152-4971            Impact factor:   1.987


  4 in total

Review 1.  Running the full human developmental clock in interspecies chimeras using alternative human stem cells with expanded embryonic potential.

Authors:  Justin Thomas; Ludovic Zimmerlin; Jeffrey S Huo; Michael Considine; Leslie Cope; Elias T Zambidis
Journal:  NPJ Regen Med       Date:  2021-05-17

Review 2.  Fumarylacetoacetate hydrolase gene as a knockout target for hepatic chimerism and donor liver production.

Authors:  Ellen L Larson; Dong Jin Joo; Erek D Nelson; Bruce P Amiot; Rajagopal N Aravalli; Scott L Nyberg
Journal:  Stem Cell Reports       Date:  2021-10-21       Impact factor: 7.765

Review 3.  In Vivo Generation of Organs by Blastocyst Complementation: Advances and Challenges.

Authors:  Konstantina-Maria Founta; Costis Papanayotou
Journal:  Int J Stem Cells       Date:  2022-05-30       Impact factor: 3.011

4.  Limited Expansion of Human Hepatocytes in FAH/RAG2-Deficient Swine.

Authors:  Erek David Nelson; Ellen Larson; Dong Jin Joo; Shennen Mao; Jaime Glorioso; Anan Abu Rmilah; Wei Zhou; Yao Jia; Taofic Mounajjed; Min Shi; Melanie Bois; Adam Wood; Fang Jin; Kristin Whitworth; Kevin Wells; Anna Spate; Melissa Samuel; Anna Minshew; Eric Walters; Piero Rinaldo; Joseph B Lillegard; Aaron Johnson; Bruce Amiot; Raymond Hickey; Randall Prather; Jeffrey L Platt; Scott L Nyberg
Journal:  Tissue Eng Part A       Date:  2021-10-07       Impact factor: 3.845

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.